Requirement for mevalonate in cycling cells: Quantitative and temporal aspects
- 1 October 1988
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 137 (1) , 133-140
- https://doi.org/10.1002/jcp.1041370116
Abstract
In order to investigate a requirement for isoprenoid compounds in the cell cycle, DNA synthesis was examined in cultured Chinese hamster ovary cells in which mevalonate biosynthesis was blocked with mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. Treatment of exponentially-growing cultures with mevinolin led to a decline in DNA synthesis and cell cycle arrest in G1. Synchronous DNA synthesis and cell division could be restored in the arrested cultures, in the absence of exogenous mevalonate, by removing the inhibitor from the culture thereby allowing expression of an induced level of HMG-CoA reductase. In order to quantitate the mevalonate requirement for entry into S phase, recovery of DNA synthesis was made dependent upon added mevalonate by preventing the induction of the enzyme using 25-hydroxycholesterol, a specific repressor of HMG-CoA reductase synthesis. When cultures were treated with both inhibitors, optimal recovery of DNA synthesis was obtained with 200 μg/ml mevalonate following an 8 h lag, whereas a progressively longer lag-time was found with lower concentrations of mevalonate. Exogenous dolichol, ubiquinone, or isopentenyladenine had no effect on the arrest or recovery of DNA synthesis. Cholesterol was required during the arrest incubation for cell viability, but was not sufficient for recovery in the absence of mevalonate. The recovery of DNA synthesis by 200 μg/ml mevalonate, which was maximal 14–16 h after the addition of mevalonate, only required that the mevalonate be present for the first 4 h, whereas more than an 8-h incubation was required for maximal recovery with 25 μg/ml mevalonate. Maximal recovery at either concentration of mevalonate was achieved after approximately 400 fmol mevalonate/μg protein was incorporated into non-saponifiable lipids. This quantity represents approximately 0.1% of the mevalonate required for the synthesis of total cellular isoprenoid compounds. The results indicate that production of a quantitatively minor product(s) of mevalonate metabolism is required during the first 4 h following release of the block before other cellular events necessary for entry into S phase can occur.This publication has 30 references indexed in Scilit:
- Role of biosynthesis of cholesterol and isoprenoid derivatives in regulation of G1 progression and cell proliferation of 3T6 cellsJournal of Cellular Physiology, 1987
- A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solutionCytometry, 1983
- Standardized shake-off to synchronize cultured CHO cellsMutation Research Letters, 1983
- Uptake of dolichol into cultured cellsFEBS Letters, 1982
- Linkage of the isoprenoid biosynthetic pathway with induction of DNA synthesis in mouse lymphocytes effects of compactin on mitogen-induced lymphocytes in serum-free mediumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Enhanced sterol synthesis in concanavalin A‐stimulated lymphocytes: Correlation with phospholipid synthesis and DNA synthesisJournal of Cellular Physiology, 1979
- Inhibitory Effects on Lipid Metabolismn in Cultured Cells of ML‐236B, a Potent Inhibitor of 3‐Hydroxt‐3‐methylglutaryl‐Cornzyme‐A ReductaseEuropean Journal of Biochemistry, 1978
- Lipid requirement for cell cyclingExperimental Cell Research, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Inhibition of cell growth by oxygenated derivatives of cholesterolNature, 1974